University of Pittsburgh Cancer Institute (UPCI)

Leadership

David A. Geller, MD, FACS

Dr. Geller is the Richard L. Simmons Professor of Surgery at the University of Pittsburgh School of Medicine, Co-Director of the UPMC Liver Cancer Center, and Co-Leader of Liver Cancer at the University of Pittsburgh Cancer Institute. Dr. Geller earned his medical degree at Northwestern University Medical School in Chicago, Illinois. He served his residency in general surgery at UPMC, and completed a fellowship in transplantation surgery at UPMC’s Thomas E. Starzl Transplantation Institute. He joined the faculty at the University of Pittsburgh School of Medicine in July of 1998. Dr. Geller’s current research interests include gene therapy for liver cancer, 3D image-guided liver surgery, and molecular mechanisms of liver injury. He has been awarded three research-related patents, and his research has received honors from institutions including the American College of Surgeons. Dr. Geller is a member of numerous professional and scientific societies including the Society of University Surgeons, Society of Surgical Oncology, and American Society of Transplant Surgeons. Currently, he is President-Elect of the Society of University Surgeons. He has published more than 160 scientific research papers and chapters, and has presented at more than 275 meetings and seminars.

David L. Bartlett, MD

Dr. Bartlett is the Bernard Fisher Professor of Surgery and Chief of the Division of Surgical Oncology at the University of Pittsburgh School of Medicine. He is the Co-Leader for both Liver Cancer and Surgical Oncology at the University of Pittsburgh Cancer Institute (UPCI), as well as the Director of Multidisciplinary Clinics, and the Director of the David D. Koch Regional Perfusion Cancer Therapy Center. He received his MD at Northwestern University Medical School. His experience includes surgical training at the Hospital of the University of Pennsylvania, clinical research at M.D. Anderson Cancer Center, basic science research at the University of Pennsylvania, a surgical oncology training fellowship at Memorial Sloan-Kettering Cancer Center, and he served as a senior investigator at the National Cancer Institute. While Dr. Bartlett’s clinical interests include all aspects of surgical oncology, he specializes in the management of hepatobiliary malignancies. An active surgeon, he performs both conventional treatment and chemoperfusion, and his clinical research is focused on the development of surgical procedures for the regional treatment of malignant neoplasms, including a simplified technique for isolated liver perfusion for patients with unresectable metastatic tumors in the liver, as well as hyperthermic peritoneal perfusion for peritoneal carcinomatosis. He is a member of the Society of Surgical Oncology, the American Association for Cancer Research, the American Society of Clinical Oncologists, and the American Society of Gene Therapy.